NPS Pharmaceuticals Reports Q3 EPS $-0.04 vs $-0.16 Est; Revenues $27.02M vs $28.18M Est
Tickers: NPSP
Get News First. Profit Faster
With Benzinga Professional get unlimited access to ALL content! PLUS:
- REALTIME NEWSFEED
- REALTIME AUDIO NEWS
- FULL CALENDAR SUITE
- CHAT WITH OUR NEWS DESK
RECENT PRO ALERTS
Goldman Sachs Maintains Sell on Progressive Corporation (The), Raises PT to $22.00
12:36pm - April 14, 2013Oppenheimer Suspends Outperform Rating on Broadridge Financial Solutions, Inc.
12:35pm - April 14, 2013Goldman Sachs Maintains Buy on Walgreen Co., Raises PT to $53.00
12:33pm - April 14, 2013
Partner Network